Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Schizophrenia

Free Subscription Articles published in Neurosci Lett Retrieve available abstracts of 54 articles: HTML format

Single Articles

July 2021
1. VALES K, Holubova K
   Minireview: Animal model of schizophrenia from the perspective of behavioral pharmacology: effect of treatment on cognitive functions.
   Neurosci Lett. 2021 Jul 2:136098. doi: 10.1016/j.neulet.2021.136098.
   PubMed     Abstract available
   
   
   June 2021
2. RAMPINO A, Annese T, Torretta S, Tamma R, et al
   Involvement of Vascular Endothelial Growth Factor in schizophrenia.
   Neurosci Lett. 2021 Jun 30:136093. doi: 10.1016/j.neulet.2021.136093.
   PubMed     Abstract available
   
   
   
3. ZHANG Q, He H, Cao B, Gao R, et al
   Analysis of cognitive impairment in schizophrenia based on machine learning: Interaction between psychological stress and immune system.
   Neurosci Lett. 2021;760:136084.
   PubMed     Abstract available
   
   
   
4. SEILLIER A
   The endocannabinoid system as a therapeutic target for schizophrenia: failures and potentials.
   Neurosci Lett. 2021 Jun 16:136064. doi: 10.1016/j.neulet.2021.136064.
   PubMed     Abstract available
   
   
   
5. PATRIK S, Filip S
   Brain ventricular volume changes in schizophrenia. A narrative review.
   Neurosci Lett. 2021 Jun 16:136065. doi: 10.1016/j.neulet.2021.136065.
   PubMed     Abstract available
   
   
   
6. ANDROVICOVA R, Pfaus JG, Ovsepian SV
   Estrogen Pendulum in Schizophrenia and Alzheimer's Disease: Review of Therapeutic Benefits and Outstanding Questions.
   Neurosci Lett. 2021 Jun 8:136038. doi: 10.1016/j.neulet.2021.136038.
   PubMed     Abstract available
   
   
   
7. KOLAR D, Kleteckova L, Brozka H, Vales K, et al
   Mini-Review: Brain Energy Metabolism and its Role in Animal Models of Depression, Bipolar Disorder, Schizophrenia and Autism.
   Neurosci Lett. 2021 Jun 4:136003. doi: 10.1016/j.neulet.2021.136003.
   PubMed     Abstract available
   
   
   April 2021
8. MEIRON O, David J, Yaniv A
   Left prefrontal transcranial direct-current stimulation reduces symptom-severity and acutely enhances working memory in schizophrenia.
   Neurosci Lett. 2021;755:135912.
   PubMed     Abstract available
   
   
   January 2021
9. GU S, Cui F, Yin J, Fang C, et al
   Altered mRNA expression levels of autophagy- and apoptosis-related genes in the FOXO pathway in schizophrenia patients treated with olanzapine.
   Neurosci Lett. 2021;746:135669.
   PubMed     Abstract available
   
   
   
10. MATAS E, William Deakin JF, Toro CT
    Abnormal Expression of Post-Synaptic Proteins in Prefrontal Cortex of Patients with Schizophrenia.
    Neurosci Lett. 2021 Jan 10:135629. doi: 10.1016/j.neulet.2021.135629.
    PubMed     Abstract available
    
    
    
11. CAI Y, Xing L, Yang T, Chai R, et al
    The neurodevelopmental role of dopaminergic signaling in neurological disorders.
    Neurosci Lett. 2021;741:135540.
    PubMed     Abstract available
    
    
    December 2020
12. ABE K, Chiba Y, Katsuse O, Takahashi Y, et al
    Exploratory investigation on antibodies to GluN1 and cognitive dysfunction in patients with chronic autoimmune psychosis.
    Neurosci Lett. 2020;743:135588.
    PubMed     Abstract available
    
    
    
13. ZHU L, Wu X, Xu B, Zhao Z, et al
    The Machine Learning Algorithm for the Diagnosis of Schizophrenia on the basis of Gene Expression in Peripheral Blood.
    Neurosci Lett. 2020 Dec 24:135596. doi: 10.1016/j.neulet.2020.135596.
    PubMed     Abstract available
    
    
    
14. YU T, Li Y, Li N, Huang J, et al
    Abnormal functional connectivity of motor circuit in the schizophrenic patients with tardive dyskinesia: a resting-state fMRI study.
    Neurosci Lett. 2020 Dec 3:135548. doi: 10.1016/j.neulet.2020.135548.
    PubMed     Abstract available
    
    
    November 2020
15. WATSON CJ, Thomas RH, Solomon T, Michael BD, et al
    COVID-19 and psychosis risk: real or delusional concern?
    Neurosci Lett. 2020 Nov 18:135491. doi: 10.1016/j.neulet.2020.135491.
    PubMed     Abstract available
    
    
    June 2020
16. O'TUATHAIGH CMP, Desbonnet L, Payne C, Petit E 1st, et al
    Ethologically based behavioural and neurochemical characterisation of mice with isoform-specific loss of dysbindin-1A in the context of schizophrenia.
    Neurosci Lett. 2020 Jun 29:135218. doi: 10.1016/j.neulet.2020.135218.
    PubMed     Abstract available
    
    
    
17. JUNG S, Kim JH, Sung G, Ko YG, et al
    Uncinate fasciculus white matter connectivity related to impaired social perception and cross-sectional and longitudinal symptoms in patients with schizophrenia spectrum psychosis.
    Neurosci Lett. 2020 Jun 10:135144. doi: 10.1016/j.neulet.2020.135144.
    PubMed     Abstract available
    
    
    May 2020
18. FERREIRA FR, de Moura NSB, Camina LH, Pombo TR, et al
    Resveratrol ameliorates the effect of maternal immune activation associated with schizophrenia in adulthood offspring.
    Neurosci Lett. 2020 May 27:135100. doi: 10.1016/j.neulet.2020.135100.
    PubMed     Abstract available
    
    
    
19. BANI-FATEMI A, Roy A, Dai N, Dada O, et al
    Genome-wide association study of aggression and violence in schizophrenia.
    Neurosci Lett. 2020 May 20:135061. doi: 10.1016/j.neulet.2020.135061.
    PubMed     Abstract available
    
    
    
20. ZHUO C, Xu X, Lin X, Chen M, et al
    Depressive symptoms combined with auditory hallucinations are accompanied with severe gray matter brain impairments in patients with first-episode untreated schizophrenia - A pilot study in China.
    Neurosci Lett. 2020 May 14:135033. doi: 10.1016/j.neulet.2020.135033.
    PubMed     Abstract available
    
    
    April 2020
21. ZHAO Z, Xu G, Shen Z, Grunebaum M, et al
    The Effect of Auditory Verbal Hallucinations on the Relationship between Spontaneous Brain Activity and intraventricular Brain Temperature in Patients with Drug-Naive Schizophrenia.
    Neurosci Lett. 2020 Apr 20:134933. doi: 10.1016/j.neulet.2020.134933.
    PubMed     Abstract available
    
    
    March 2020
22. TERESHKINA EB, Boksha IS, Prokhorova TA, Savushkina OK, et al
    Decrease in 130 kDa- amyloid protein precursor protein (app) and APP protein ratio in schizophrenia platelets.
    Neurosci Lett. 2020 Mar 16:134914. doi: 10.1016/j.neulet.2020.134914.
    PubMed     Abstract available
    
    
    February 2020
23. CALABRO M, Porcelli S, Crisafulli C, Albani D, et al
    Genetic variants associated with psychotic symptoms across psychiatric disorders.
    Neurosci Lett. 2020;720:134754.
    PubMed     Abstract available
    
    
    December 2019
24. SUN Q, Zhao Y, Zhang K, Su H, et al
    An association study between methamphetamine use disorder with psychosis and polymorphisms in MiRNA.
    Neurosci Lett. 2019;717:134725.
    PubMed     Abstract available
    
    
    November 2019
25. CHEN L, Li XS, Zheng GE, Xie GJ, et al
    Peripheral blood BDNF-TrkB signaling in first-episode, drug-free patients with major depressive disorder and schizophrenia.
    Neurosci Lett. 2019 Nov 8:134618. doi: 10.1016/j.neulet.2019.134618.
    PubMed     Abstract available
    
    
    October 2019
26. BANKI L, Buki A, Horvath G, Kekesi G, et al
    Distinct changes in chronic pain sensitivity and oxytocin receptor expression in a new rat model (Wisket) of schizophrenia.
    Neurosci Lett. 2019 Oct 16:134561. doi: 10.1016/j.neulet.2019.134561.
    PubMed     Abstract available
    
    
    
27. LIU YP, Meng JH, Wu X, Xu FL, et al
    Rs1625579 polymorphism in the MIR137 gene is associated with the risk of schizophrenia: an updated meta-analysis.
    Neurosci Lett. 2019 Oct 3:134535. doi: 10.1016/j.neulet.2019.134535.
    PubMed     Abstract available
    
    
    September 2019
28. LIANG S, Chen S, Zhao L, Miao D, et al
    Categorization of emotional faces in schizophrenia patients: an ERP study.
    Neurosci Lett. 2019 Sep 10:134493. doi: 10.1016/j.neulet.2019.134493.
    PubMed     Abstract available
    
    
    July 2019
29. FOUTE NELONG T, Manduca JD, Zonneveld PM, Perreault ML, et al
    Asenapine maleate normalizes low frequency oscillatory deficits in a neurodevelopmental model of schizophrenia.
    Neurosci Lett. 2019;711:134404.
    PubMed     Abstract available
    
    
    May 2019
30. GHOTBI RAVANDI S, Shabani M, Bashiri H, Saeedi Goraghani M, et al
    Ameliorating effects of berberine on MK-801-induced cognitive and motor impairments in a neonatal rat model of schizophrenia.
    Neurosci Lett. 2019 May 16. pii: S0304-3940(19)30347.
    PubMed     Abstract available
    
    
    April 2019
31. ZHUANG H, Liu R, Wu C, Meng Z, et al
    Multimodal classification of drug-naive first-episode schizophrenia combining anatomical, diffusion and resting state functional resonance imaging.
    Neurosci Lett. 2019 Apr 22. pii: S0304-3940(19)30281.
    PubMed     Abstract available
    
    
    November 2018
32. NATHOU C, Duprey E, Simon G, Razafimandimby A, et al
    Effects of low- and high-frequency repetitive transcranial magnetic stimulation on long-latency auditory evoked potentials.
    Neurosci Lett. 2018;686:198-204.
    PubMed     Abstract available
    
    
    October 2018
33. JACOBI AA, Halawani S, Lynch DR, Lin H, et al
    Neuronal serine racemase associates with Disrupted-In-Schizophrenia-1 and DISC1 agglomerates: Implications for schizophrenia.
    Neurosci Lett. 2018 Oct 31. pii: S0304-3940(18)30737.
    PubMed     Abstract available
    
    
    
34. HAN M, Deng C
    BDNF as a pharmacogenetic target for antipsychotic treatment of schizophrenia.
    Neurosci Lett. 2018 Oct 9. pii: S0304-3940(18)30691.
    PubMed     Abstract available
    
    
    September 2018
35. KANG Y, Huang K, Cai S, Wang H, et al
    Association between function and structure of the triple network and catechol-O-methyltransferase val(158)met polymorphism in the first episode schizophrenia.
    Neurosci Lett. 2018 Sep 18. pii: S0304-3940(18)30639.
    PubMed     Abstract available
    
    
    
36. LUO X, Qi Y, Wang H, Wang Y, et al
    Prefrontal cortex dysfunction during verbal fluency task after atypicalantipsychotic treatment in schizophrenia: A near-infrared spectroscopy imaging study.
    Neurosci Lett. 2018;686:101-105.
    PubMed     Abstract available
    
    
    August 2018
37. LI XS, Wu HT, Yu Y, Chen GY, et al
    Increased serum FGF2 levels in first-episode, drug-free patients with schizophrenia.
    Neurosci Lett. 2018 Aug 30. pii: S0304-3940(18)30590.
    PubMed     Abstract available
    
    
    
38. CHO SJ, Kim MK, Bang SY, Bang M, et al
    White matter integrity associated with severity reductions in positive symptoms after amisulpride treatment in drug-free patients with schizophrenia.
    Neurosci Lett. 2018 Aug 26. pii: S0304-3940(18)30581.
    PubMed     Abstract available
    
    
    
39. LU JY, Tiwari AK, Zai GC, Rastogi A, et al
    Association study of Disrupted-In-Schizophrenia-1 Gene variants and Tardive Dyskinesia.
    Neurosci Lett. 2018 Aug 14. pii: S0304-3940(18)30537.
    PubMed     Abstract available
    
    
    
40. ARABSKA J, Lucka A, Strzelecki D, Wysokinski A, et al
    In schizophrenia serum level of neurotrophin-3 (NT-3) is increased only if depressive symptoms are present.
    Neurosci Lett. 2018;684:152-155.
    PubMed     Abstract available
    
    
    
41. ZHOU W, Chang W, Yan Y, Shen L, et al
    Pharmacogenetics Analysis of Serotonin Receptor Gene Variants and Clinical Response to Risperidone in Han Chinese Schizophrenic Patients.
    Neurosci Lett. 2018 Aug 3. pii: S0304-3940(18)30532.
    PubMed     Abstract available
    
    
    May 2018
42. DING N, Li Z, Liu Z
    Escitalopram augmentation improves negative symptoms of treatment resistant schizophrenia patients - A randomized controlled trial.
    Neurosci Lett. 2018 May 28. pii: S0304-3940(18)30371.
    PubMed     Abstract available
    
    
    March 2018
43. FANNI D, Gerosa C, Rais M, Ravarino A, et al
    The role of neuropathological markers in the interpretation of neuropsychiatric disorders: Focus on fetal and perinatal programming.
    Neurosci Lett. 2018;669:75-82.
    PubMed     Abstract available
    
    
    
44. MURRU A, Carpiniello B
    Duration of untreated illness as a key to early intervention in schizophrenia: A review.
    Neurosci Lett. 2018;669:59-67.
    PubMed     Abstract available
    
    
    
45. SPANIEL F, Bakstein E, Anyz J, Hlinka J, et al
    Relapse in schizophrenia: Definitively not a bolt from the blue.
    Neurosci Lett. 2018;669:68-74.
    PubMed     Abstract available
    
    
    January 2018
46. ZAI CC, Manchia M, Zai GC, Woo J, et al
    Association study of BDNF and DRD3 genes with Alcohol Use Disorder in Schizophrenia.
    Neurosci Lett. 2018 Jan 18. pii: S0304-3940(18)30039.
    PubMed     Abstract available
    
    
    October 2017
47. GRISKOVA-BULANOVA I, Dapsys K, Melynyte S, Voicikas A, et al
    40Hz auditory steady-state response in schizophrenia: Sensitivity to stimulation type (clicks versus flutter amplitude-modulated tones).
    Neurosci Lett. 2017 Oct 16. pii: S0304-3940(17)30843.
    PubMed     Abstract available
    
    
    September 2017
48. KANG SG, Chee IS, Chang HS, Na KS, et al
    Polymorphism of the SNAP25 gene is associated with symptom improvement in schizophrenic patients treated with amisulpride.
    Neurosci Lett. 2017;661:46-50.
    PubMed     Abstract available
    
    
    August 2017
49. LISEK M, Boczek T, Zylinska L
    Calcium as a Trojan horse in mental diseases-The role of PMCA and PMCA-interacting proteins in bipolar disorder and schizophrenia.
    Neurosci Lett. 2017 Aug 2. pii: S0304-3940(17)30642.
    PubMed     Abstract available
    
    
    June 2017
50. ZHU XL, Tan SP, Wang ZR, Zhang JG, et al
    P50 suppression deficits and psychopathology in Han Chinese patients with schizophrenia.
    Neurosci Lett. 2017 Jun 9. pii: S0304-3940(17)30489.
    PubMed     Abstract available
    
    
    May 2017
51. ZHANG L, Li B, Wang H, Li L, et al
    Decreased middle temporal gyrus connectivity in the language network in schizophrenia patients with auditory verbal hallucinations.
    Neurosci Lett. 2017 May 29. pii: S0304-3940(17)30438.
    PubMed     Abstract available
    
    
    April 2017
52. FAN N, Tan Y, Yang F, Tian L, et al
    Effect of Risperidone on Serum Homocysteine Levels in First-episode, Drug-naive Patients with Schizophrenia.
    Neurosci Lett. 2017 Apr 15. pii: S0304-3940(17)30326.
    PubMed     Abstract available
    
    
    
53. SUDESH R, Thirunavukkarasu P, Rajendran P, John S, et al
    Minor allele C of rs12807809 polymorphism in NRGN contributes to the severity of psychosis in patients with Schizophrenia in South Indian population.
    Neurosci Lett. 2017 Apr 4. pii: S0304-3940(17)30299.
    PubMed     Abstract available
    
    
    March 2017
54. LIU W, Liu F, Xu X, Bai Y, et al
    Replicated association between the European GWAS locus rs10503253 at CSMD1 and schizophrenia in Asian population.
    Neurosci Lett. 2017 Mar 23. pii: S0304-3940(17)30259.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: